Ehave Inc (EHVVF)

Ehave, Inc. (OTC: EHVVF) has completed the first of three planned phases of its studies with the University of Melbourne to determine the cause and possible cure for hallucinogen-persisting perception disorder (HPPD).

After a full review of healthcare provider Ehave Inc.'s (OTC Pink: EHVVF) IND application, the U.S.

The world of psychedelics is getting a crossover with another category in the millennial catalog of trendy investments: NFTs.

Ehave, Inc. (OTC Pink: EHVVF) is a leading healthcare services and technology company focused on progressing psychedelics to therapeutics by engineering novel compounds and new treatment protocols for treating brain health.

Mycotopia Therapies (OTCPK:TPIA) subsidiary of Ehave, Inc. (OTCPK:EHVVF), has signed a definitive agreement to complete a triangular merger with Ei.Ventures, to form PSLY.COM. The companies anticipate closing the transaction on or about July 30, 2022.

Ehave, Inc. (OTC Pink: EHVVF), a healthcare company developing digital solutions in the medical cannabis and mental health sectors, reported that its wholly-owned subsidiary,...

The Week In Psychedelics

Greenlight Distribution Hires Erik Elder As New Director Of Sales Greenlight Distribution, a leading seller of product...

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...